Tyrosine-phosphorylated Vav1 as a Point of Integration for T-cell Receptor- and CD28-mediated Activation of JNK, p38, and Interleukin-2 Transcription* 210
暂无分享,去创建一个
T. Hofmann | W. Dröge | M. Schmitz | Steffen P. Hehner | Thomas G. Hofmann | M. Lienhard Schmitz | Oliver Dienz | Wulf Dröge | S. Hehner | O. Dienz
[1] B. Mayer,et al. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. , 1998, Immunity.
[2] R. Schwartz,et al. T-cell clonal anergy. , 1997, Cold Spring Harbor symposia on quantitative biology.
[3] C. Martínez-A,et al. IL-2-induced cellular events. , 1998, Critical reviews in immunology.
[4] D. Cantrell. Lymphocyte signalling: A coordinating role for Vav? , 1998, Current Biology.
[5] M. Berridge. Inositol trisphosphate and calcium signalling , 1993, Nature.
[6] A. Weiss,et al. A Guanine Nucleotide Exchange Factor-independent Function of Vav1 in Transcriptional Activation* , 2000, The Journal of Biological Chemistry.
[7] S. Bromley,et al. The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.
[8] A. Rao,et al. Transcriptional regulation of the IL-2 gene. , 1995, Current opinion in immunology.
[9] James S. Song,et al. The Src Homology 2 Domain of Vav Is Required for Its Compartmentation to the Plasma Membrane and Activation of C-Jun Nh2-Terminal Kinase 1 , 2000, The Journal of experimental medicine.
[10] M. Turner,et al. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. White,et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.
[12] D. Olive,et al. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras , 1994, The Journal of experimental medicine.
[13] D. Fearon,et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. , 1998, Immunity.
[14] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[15] Michael Loran Dustin,et al. Making the T cell receptor go the distance: a topological view of T cell activation. , 1997, Immunity.
[16] T. Mustelin,et al. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. , 1996, Immunity.
[17] Melvin Cohn,et al. A Theory of Self-Nonself Discrimination , 1970, Science.
[18] M. Barbacid,et al. Mechanism of activation of the vav protooncogene. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[19] M. Iacobelli,et al. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. , 1997, Journal of immunology.
[20] Masahiko Hibi,et al. JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.
[21] T. Tan,et al. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. , 1999, Journal of immunology.
[22] M. Karin,et al. Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. , 1998, Immunity.
[23] T. Pawson,et al. HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. , 1996, The EMBO journal.
[24] O. Hobert,et al. SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin. , 1996, Oncogene.
[25] M. Barbacid,et al. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.
[26] S. Bagrodia,et al. Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.
[27] E. Harhaj,et al. IκB Kinases Serve as a Target of CD28 Signaling* , 1998, The Journal of Biological Chemistry.
[28] M. Karin,et al. Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.
[29] D. Bar-Sagi,et al. Crystal Structure of the Dbl and Pleckstrin Homology Domains from the Human Son of Sevenless Protein , 1998, Cell.
[30] A. Weiss,et al. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites , 1997, Molecular and cellular biology.
[31] B. Schraven,et al. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins. , 1999, Immunology today.
[32] M. Davis,et al. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.
[33] C. Der,et al. Lck regulates Vav activation of members of the Rho family of GTPases , 1997, Molecular and cellular biology.
[34] Roger J. Davis,et al. The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins , 1999, Molecular and Cellular Biology.
[35] K. Schuebel,et al. Phosphorylation‐dependent and constitutive activation of Rho proteins by wild‐type and oncogenic Vav‐2 , 1998, The EMBO journal.
[36] L. Samelson,et al. Complex complexes: signaling at the TCR. , 1996, Immunity.
[37] M. Barbacid,et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.
[38] T. Curran,et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun , 1993, Nature.
[39] A. Ullrich,et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.
[40] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[41] N. Varin‐Blank,et al. hSiah2 Is a New Vav Binding Protein Which Inhibits Vav-Mediated Signaling Pathways , 1999, Molecular and Cellular Biology.
[42] F. Alt,et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.
[43] L. Samelson,et al. LAT The ZAP-70 Tyrosine Kinase Substrate that Links T Cell Receptor to Cellular Activation , 1998, Cell.
[44] F. Romero,et al. Structure and function of vav. , 1996, Cellular signalling.
[45] J. Woodgett,et al. MLK‐3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. , 1996, The EMBO journal.
[46] R. Zamoyska,et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. , 1997, Immunity.
[47] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[48] P. Crespo,et al. The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.
[49] W. Fiers,et al. The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.
[50] J. Wu,et al. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. , 1996, Immunity.
[51] M Geyer,et al. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. , 1999, Molecular cell.
[52] G. Koretzky,et al. Three domains of SLP-76 are required for its optimal function in a T cell line. , 1997, Journal of immunology.
[53] J. Brugge,et al. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1 , 1998, Current Biology.
[54] K. Tedford,et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.
[55] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.
[56] G. Crabtree,et al. Calcineurin Is a Key Signaling Enzyme in T Lymphocyte Activation and the Target of the Immunosuppressive Drugs Cyclosporin A and FK506 a , 1993, Annals of the New York Academy of Sciences.
[57] J. Yasuda,et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.
[58] J. Wu,et al. A functional T-cell receptor signaling pathway is required for p95vav activity , 1995, Molecular and cellular biology.
[59] L. Tuosto,et al. Fyn and ZAP-70 Are Required for Vav Phosphorylation in T Cells Stimulated by Antigen-presenting Cells* , 1998, The Journal of Biological Chemistry.
[60] M. Karin,et al. Calcineurin preferentially synergizes with PKC‐θ to activate JNK and IL‐2 promoter in T lymphocytes , 1998, The EMBO journal.
[61] E. Nishida,et al. A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses , 1997, The EMBO journal.
[62] X. Bustelo,et al. Biological and Regulatory Properties of Vav-3, a New Member of the Vav Family of Oncoproteins , 1999, Molecular and Cellular Biology.